Product ID:102 8869,KODAK READYMATIC DENTAL DEVELOPER AND REPLENISHER
MSDS Date:02/09/2000
FSC:6525
NIIN:01-168-0528
Kit Part:Y
MSDS Number: CKWGR

EASTMAN KODAK COMPANY

343 STATE STREET
ROCHESTER, NY 14650
US

Emergency Phone: 716-722-5151

Info Phone: 800- 242-2424

Preparer: NOT PROVIDED

Cage: 19139

EASTMAN KODAK CO US CUSTOMER SERVICE/GOVERNMENT SALES

ROCHESTER, NY 14650-3129 US

Telephone: 800-828-6203

Cage: 5K871

WATER

CAS: 7732-18-5

RTECS: ZC0110000

SODIUM SULFITE

CAS: 7757-83-7

RTECS: WE2150000

OSHA PEL NOT PROVIDED

ACGIH TLV: NOT PROVIDED

HYDROQUINONE

CAS: 123-31-9

RTECS: MX3500000

OSHA PEL 2 MG/M3

ACGIH TLV: 2 MG/M3

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB

SODIUM BICARBONATE

CAS: 144-55-8

RTECS: VZ0950000

OSHA PEL NOT PROVIDED

ACGIH TLV: NOT PROVIDED

POTASSIUM CARBONATE

CAS: 584-08-7

RTECS: TS7750000

OSHA PEL NOT PROVIDED

ACGIH TLV: NOT PROVIDED

4-(HYDROXYMETHYL)-4-METHYL-1-PHENYL-3-PYRAZOLIDONE/

CAS: 13047-13-7

OSHA PEL NOT PROVIDED

ACGIH TLV: NOT PROVIDED

LD50 LC50 Mixture:NOT PROVIDED
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION: EXPECTED TO BE A LOW
HAZARD FOR USUAL INDUSTRIAL OR COMMERCIAL HANDLING BY TRAINED
PERSONNEL. IN CONTACT WITH STRONG ACIDS OR IF HEATED, SULFITES MAY
LIBERATE SULFUR DIOXIDE GAS. SULFUR D IOXIDE GAS IS IRRITATING TO
THE RESPIRATORY TRACT. SOME ASTHMATICS OR HYPERSENSITIVE
INDIVIDUALS MAY EXPERIENCE DIFFICULT BREATHING. EYES: CAUSES
IRRITATION. SKIN: MAY CAUSE ALLERGIC SKIN REACTION BAS ED ON HUMAN
EXPERIENCE. MAY CAUSE SKIN DEPIGMENTATION. PROLONGED OR REPEATED
CONTACT WITH AQUEOUS SOLUTIONS MAY CAUSE IRRITATION. INGESTION:
HARMFUL IF SWALLOWED.
Explanation of Carcinogenicity:CARCINOGENICITY CLASSIFICATION
(COMPONENTS PRESENT AT 0.1% OR MORE): - INTERNATIONAL AGENCY FOR
RESEARCH ON CANCER (IARC): NONE - AMERICAN CONFERENCE OF
GOVERNMENTAL INDUSTRIAL HYGIENISTS (ACGIH): HYD ROQUINONE; A3,
ANIMAL CARCINOGEN. - NATIONAL TOXICOLOGY PROGRAM (NTP): NONE -
OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION (OSHA): NONE
Effects of Overexposure:INHALATION: IN CONTACT WITH STRONG ACIDS OR IF
HEATED, SULFITES MAY LIBERATE SULFUR DIOXIDE GAS. SULFUR DIOXIDE
GAS IS IRRITATING TO THE RESPIRATORY TRACT. SOME ASTHMATICS OR
HYPERSENSITIVE INDIVIDUA LS MAY EXPERIENCE DIFFICULT BREATHING.
EYES: CAUSES IRRITATION. SKIN: MAY CAUSE SKIN DEPIGMENTATION.
PROLONGED OR REPEATED CONTACT WITH AQUEOUS SOLUTIONS MAY CAUSE
IRRITATION.
Medical Cond Aggravated by Exposure:SOME ASTHMATICS OR HYPERSENSITIVE
INDIVIDUALS MAY EXPERIENCE DIFFICULT BREATHING.

First Aid:INHALATION: IF SYMPTOMATIC, MOVE TO FRESH AIR. TREAT
SYMPTOMATICALLY. GET MEDICAL ATTENTION IF SYMPTOMS PERSIST. EYES:
IMMEDIATELY FLUSH WITH PLENTY OF WATER FOR AT LEAST 15 MINUTES. GET
MEDICAL ATTEN TION IF SYMPTOMS OCCUR. SKIN: IMMEDIATELY FLUSH WITH
PLENTY OF WATER FOR AT LEAST 15 MINUTES WHILE REMOVING CONTAMINATED
CLOTHING AND SHOES. IF SKIN IRRITATION OR AN ALLERGIC SKIN REACTION
DEVELOPS, G ET MEDICAL ATTENTION. INGESTION: ONLY INDUCE VOMITING
AT THE INSTRUCTION OF MEDICAL PERSONNEL. DRINK 1-2 GLASSES OF
WATER. NEVER GIVE ANYTHING BY MOUTH TO AN UNCONSCIOUS PERSON. CALL
A PHYSICIAN OR PO ISON CONTROL CENTER IMMEDIATELY.

Extinguishing Media:USE APPROPRIATE AGENT FOR ADJACENT FIRE.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
PROTECTIVE CLOTHING.
Unusual Fire/Explosion Hazard:NONE

Spill Release Procedures:FLUSH TO SEWER WITH LARGE AMOUNT OF WATER.
Neutralizing Agent:NOT PROVIDED

Handling and Storage Precautions:KEEP CONTAINER CLOSED.
Other Precautions:AVOID BREATHING MIST OR VAPOR. AVOID CONTACT WITH
EYES, SKIN, AND CLOTHING. USE WITH ADEQUATE VENTILATION. WASH
THOROUGHLY AFTER HANDLING.

Respiratory Protection:NONE SHOULD BE NEEDED. A RESPIRATOR SHOULD BE
WORN IF HAZARDOUS DECOMPOSITION PRODUCTS ARE LIKELY TO BE OR HAVE
BEEN RELEASED. RESPIRATOR TYPE: ACID GAS. SEE STABILITY AND
REACTIVITY SECTION. IF RESPI RATORS ARE USED, A PROGRAM SHOULD BE
INSTITUTED TO ASSURE COMPLIANCE WITH OSHA STANDARD 29 CFR 1910.134.
Ventilation:GOOD GENERAL VENTILATION (TYPICALLY 10 AIR CHANGES PER
HOUR) SHOULD BE USED. VENTILATION RATES SHOULD BE MATCHED TO
CONDITIONS.
Protective Gloves:WEAR IMPERVIOUS GLOVES AND PROTECTIVE CLOTHING
APPROPRIATE FOR RISK OF EXPOSURE
Eye Protection:WEAR SAFETY GLASSES WITH SIDE SHIELDS (OR GOGGLES).
Other Protective Equipment:EYE BATH, WASHING FACILITIES, SAFETY SHOWER
Work Hygienic Practices:IT IS A GOOD INDUSTRIAL HYGIENE PRACTICE TO
MINIMIZE EYE CONTACT. IT IS A GOOD INDUSTRIAL HYGIENE PRACTICE TO
MINIMIZE SKIN CONTACT.
Supplemental Safety and Health
ABBREVIATION: N/A=NOT APPLICABLE OR NOT AVAILABLE. N/K=UNKNOWN. N/P=NOT
PROVIDED. N/R=NOT RELEVANT. N/D=NOT DETERMINED. N/E=NOT
ESTABLISHED.

HCC:B3
NRC/State Lic Num:NOT RELEVANT
Boiling Pt:>100.C, 212.F
Melt/Freeze Pt:M.P/F.P Text:NOT PROVIDED
Decomp Temp:Decomp Text:NOT PROVIDED
Vapor Pres:(68F):24 MBAR (18 MM HG)
Vapor Density:0.6
Spec Gravity:1.08
pH:10.1
Viscosity:NOT PROVIDED
Evaporation Rate & Reference:NOT PROVIDED
Solubility in Water:COMPLETE
Appearance and Odor:COLORLESS LIQUID - NO ODOR
Percent Volatiles by Volume:90 WT
Corrosion Rate:NOT PROVIDED

Stability Indicator/Materials to Avoid:YES
NONE WITH COMMON MATERIALS AND CONTAMINANTS WITH WHICH THE MATERIAL MAY
REASONABLY COME INTO CONTACT.
Stability Condition to Avoid:NOT PROVIDED
Hazardous Decomposition Products:NONE (NONCOMBUSTIBLE).

Waste Disposal Methods:DISCHARGE, TREATMENT, OR DISPOSAL MAY BE SUBJECT
TO NATIONAL, STATE, OR LOCAL LAWS. FLUSH TO SEWER WITH LARGE
AMOUNTS OF WATER. SINCE EMPTIED CONTAINERS RETAIN PRODUCT RESIDUE,
FOLLOW LABEL WARNINGS E VEN AFTER CONTAINER IS EMPTIED.

Toxicological Information:IN F-344 RATS, CHRONIC ORAL ADMINISTRATION OF
HYDROQUINONE HAS RESULTED IN FORMATION OF BENIGN KIDNEY TUMORS
THOUGHT TO BE SECONDARY TO NEPHROPATHY. HYDROQUINONE-INDUCED
NEPHROPATHY FOLLOWING ORAL ADM INISTRATION HAS BEEN NOTED IN MALE
F-344 RAT, BUT NOT IN OTHER SPECIES/RAT STRAINS TESTED. ALTHOUGH AN
INCREASE IN MONONUCLEAR CELL LEUKEMIA IN F-344 FEMALE RATS HAS BEEN
REPORTED FOLLOWING CHRONIC OR AL ADMINISTRATION OF HYDROQUINONE,
THIS FINDING WAS NOT REPRODUCED IN A SUBSEQUENT STUDY. THERE WAS NO
EVIDENCE OF CARCINOGENICITY IN MALE MICE FOLLOWING CHRONIC ORAL
ADMINISTRATION OF HYDROQUINONE; S OME EVIDENCE WAS SHOWN IN FEMALE
MICE

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecological:THE FOLLOWING PROPERTIES ARE ESTIMATED FROM THE COMPONENTS
OF THE PREPARATIONS:. POTENTIAL TOXICITY FISH
LC50 MG/L: 1-10 DAPHNID EC50 MG/L:
1-10 ALGAL IC50 MG/L: 10-100 ORGANICS
READILY DEGRADABLE YES (7 DAYS) (>70%): POTENTIAL
BIOACCUMULATION: LOG POW <1 COD (APPROXIMATE G/L):
60 B OD5 (APPROXIMATE G/L): 40 POTENTIAL
TOXICITY WASTE TREATMENT MICROORGANISMS NOT AVAILABLE EC50
(MG/L):

Transport Information:OR TRANSPORTATION INFORMATION REGARDING THIS
PRODUCT CALL THE KODAK WORLDWIDE TRANSPORTATION HAZMAT HOT LINE:
(716) 722-2400 BETWEEN 8 A.M. AND 5 P.M. (EASTERN STANDARD TIME),
MONDAY THROUGH FRIDAY.

SARA Title III Information:CHEMICAL(S) SUBJECT TO THE REPORTING
REQUIREMENTS OF SECTION 313 OR TITLE III OF THE SUPERFUND
AMENDMENTS AND REAUTHORIZATION ACT (SARA) OF 1986 AND 40 CFR
PART 372: HYDROQUINONE
Federal Regulatory Information:NOT PROVIDED
State Regulatory Information:MATERIAL(S) KNOWN TO THE STATE OF
CALIFORNIA TO CAUSE CANCER: NONE - MATERIAL(S) KNOWN TO THE STATE
OF CALIFORNIA TO CAUSE ADVERSE REPRODUCTIVE EFFECTS: NONE